• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
Birx Faults WHO and China for Delayed Coronavirus Response

Birx Says WH Coronavirus Task Force Preparing to Review Distribution of Remdesivir, Email Shows

May 12, 2020
ALFREDO ORTIZ: Jobs Report Shows Economy Of Resilience

ALFREDO ORTIZ: Jobs Report Shows Economy Of Resilience

April 3, 2026
Virginia’s Expensive DEI Office Brought Back To Life With ‘Pioneer’ Boss

Virginia’s Expensive DEI Office Brought Back To Life With ‘Pioneer’ Boss

April 3, 2026
Blue States Scrambling To Keep Gender Counseling Censorship Alive After SCOTUS Ruling

Blue States Scrambling To Keep Gender Counseling Censorship Alive After SCOTUS Ruling

April 3, 2026
Power Company Faces Legal Fight For Making Too Much Energy

Power Company Faces Legal Fight For Making Too Much Energy

April 3, 2026
Tiger Woods Called Trump After Rollover Crash

Tiger Woods Called Trump After Rollover Crash

April 3, 2026
Trump Admin Declares War On Microplastics In Drinking Water

Trump Admin Declares War On Microplastics In Drinking Water

April 3, 2026
Trump Admin Still Has Long Way To Go To Make America Healthy Again, Analysts Say

Trump Admin Still Has Long Way To Go To Make America Healthy Again, Analysts Say

April 3, 2026
Central Command: US Ground Troops Now in Middle East

Comedian Ponders Trump, Jesus Comparison

April 3, 2026
School Reverses Suspension Of Pro-ICE Student After Being Called Out For Hypocrisy

School Reverses Suspension Of Pro-ICE Student After Being Called Out For Hypocrisy

April 3, 2026
Trump Threatens to Strike Iran’s Infrastructure 

Trump Threatens to Strike Iran’s Infrastructure 

April 3, 2026
Key Fund’s Demise Spells Even More Bad News For America’s Crumbling Roads

Key Fund’s Demise Spells Even More Bad News For America’s Crumbling Roads

April 3, 2026
BRANDON WEICHERT: Trump’s Iran Gamble Could End In A Desert One Catastrophe

BRANDON WEICHERT: Trump’s Iran Gamble Could End In A Desert One Catastrophe

April 3, 2026
  • Donald Trump
  • Tariffs
  • Congress
  • Faith
  • Immigration
Friday, April 3, 2026
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home IJR

Birx Says WH Coronavirus Task Force Preparing to Review Distribution of Remdesivir, Email Shows

by Meaghan Ellis
May 12, 2020 at 11:25 am
in IJR
247 16
0
Birx Faults WHO and China for Delayed Coronavirus Response

FILE PHOTO: White House Coronavirus response coordinator Dr. Deborah Birx speaks during a news conference in the Rose Garden of the White House in Washington, U.S., March 29, 2020. REUTERS/Al Drago

511
SHARES
1.5k
VIEWS
Share on FacebookShare on Twitter

White House coronavirus coordinator Dr. Deborah Birx is revealing that mistakes were made in the government’s decision making that led to errors in the allocation of the drug Remdesivir, which is currently being touted as a potential treatment for coronavirus.

According to an email Birx sent to members of the coronavirus task force and senior White House officials including infectious disease expert, Dr. Anthony Fauci, a review of the decision-making will take place, according to The Wall Street Journal, who was read the email by an official.

Birx said it will be reviewed in order to pinpoint where the “misalignment” occurred.

“We can later review the decision-making process, the lack of engagement of Task Force, and the methodology and analysis used by the data and modeling group that resulted in the misalignment of the therapeutic and on-the-ground current need in the first shipment so we can be assured this doesn’t occur in the future,” Dr. Birx said in the email from May 7.

Jonathan Ernst/Reuters

Two days after Birx’s email, the government implemented changes to how the drug is allocated. In a statement released on Saturday, the Department of Health and Human Services confirmed states would now be in charge of the allocation of the drug.

The department said the government will be shipping the drug to states and then states would distribute the drug to health systems on an as-needed basis.

Birx’s email surfaces approximately two weeks after the Food and Drug Administration granted an emergency authorization for the drug on May 1. The decision was made after a placebo-controlled, randomized trial showed significantly positive results for the drug, as previously reported on IJR.

At the time, Fauci said, “Although the results were positive from a significant, statistical standpoint, they were modest.”

Fauci also noted that while the drug was still being studied in clinical trials, the results showed that the drug signaled an important step in the right direction.

Fauci said, “Its good news but I was very serious when I said, ‘This is not the total answer, by any means, but it’s a very important first step.”

Tags: Coronavirus OutbreakDeborah Birx
Share204Tweet128
Meaghan Ellis

Meaghan Ellis

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th